15 research outputs found
Late dihydroartemisinin-piperaquine treatment failure of P. falciparum malaria attack related to insufficient dosing in an obese patient
No full textWe report the case of an obese patient who experienced late failure on day28 of a well-conducted treatment with artesunate, followed by dihydroartemisinin-piperaquine (DHA-PPQ) for a severe P. falciparum malaria attack. The same P. falciparum strain was evidenced at day0 and day28. Genotypic and phenotypic resistance tests could not explain this treatment failure. The low plasma piperaquine concentration at failure may explain the poor elimination of residual parasites
Intérêt potentiel des anti-IL17 dans la prise en charge du psoriasis en cas de pathologie tumorale associée aux HPV à haut risque oncogène (HPVHR)
No full textLes étrangers précaires exclus de l’Assurance Maladie en service de maladies infectieuses (EPSAMI) : conséquences médicales et financières
No full textContrôle sous-optimal de l’infection VIH chez les patientes transgenres, homme vers femme, en 2017, dans un centre hospitalier universitaire
No full textUse of PCR Signal and Therapeutic Drug Monitoring in a Switch Cohort Study to Tenofovir/Emtricitabine/Rilpivirine: A W96 Follow-Up
No full textIntegrase strand transfer inhibitors and neuropsychiatric adverse events in a large prospective cohort
No full textTo analyse the frequency and causes of treatment discontinuation in patients who were treated with an integrase strand transfer inhibitor (INSTI), with a focus on neuropsychiatric adverse events (NPAEs)
